Sunwin International Neutraceuticals, Inc. is a vertically integrated global leader in the manufacturing of all natural Stevia products and essential traditional Chinese medicines. Located in Qufu, China with US operations headquartered in Dallas, TX, Sunwin has been a U.S. public company since since 2004 (OTCBB: SUWN).
Sunwin is traded on the OTCBB under the symbol SUWN. For questions, please contact Dore Perler at (954) 232-5363 or email
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Sunwin products fall into two categories:
|
Stevioside
|
Traditional Chinese Medicine Formula Extracts
|
| An all natural zero calorie sweetener and dietary supplement approximately 300 times sweeter than sugar. Sunwin is one of the largest global wholesale seller with a production capacity of 300+ metric tons annually. | More than 325 traditional Chinese herbal medicine extracts are sold on a wholesale basis to domestic traditional Chinese medicine manufacturers and pharmaceutical manufacturers. |
Recent Financial Highlights
|
Fiscal Year Ended |
2011 |
2010 |
|
Revenue |
$ 9,582,631 |
$ 12,850,517 |
|
Gross Profit |
$ 1,451,780 |
$ 1,936,961 |
|
Net Income |
$ (4,910,292) |
$ (4,928,500) |
|
EPS |
$ (0.03) |
$ (0.03) |
|
Cash |
$ 10,563,413 |
$ 10,416,522 |
|
Total Assets |
$ 33,058,682 |
$ 41,317,470 |
Disclaimer:
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Sunwin International Neutraceuticals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance and expectations regarding revenues, net income and earnings. In addition, any such statements are qualified in their entirety by reference to, and are accompanied by, the following key factors that have a direct bearing on our results of operations: our ability to effectively integrate our acquisitions and to manage our growth and our inability to fully realize any anticipated benefits of acquired business; our need for additional financing which we may not be able to obtain on acceptable terms, the dilutive effect additional capital raising efforts in future periods may have on our current shareholders; our dependence on certain key personnel; the lack of various legal protections in certain agreements to which we are a party and which are material to our operations which are customarily contained in similar contracts prepared in the United States; the business operating risks and new technology in the business we seek to enter into and currently operate in; the effect of changes resulting from the political and economic policies of the Chinese government on our assets and operations located in the PRC; the influence of the Chinese government over the manner in which our Chinese subsidiaries must conduct our business activities; the limitation on our ability to receive and use our revenues effectively as a result of restrictions on currency exchange in China; our ability to enforce our rights due to policies regarding the regulation of foreign investments in China; our ability to comply with the United States Foreign Corrupt Practices Act which could subject us to penalties and other adverse consequences; and our ability to establish adequate management, legal and financial controls in the PRC.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
